106 related articles for article (PubMed ID: 26575421)
1. Enhanced therapeutic effect of Adriamycin on multidrug resistant breast cancer by the ABCG2-siRNA loaded polymeric nanoparticles assisted with ultrasound.
Bai M; Shen M; Teng Y; Sun Y; Li F; Zhang X; Xu Y; Duan Y; Du L
Oncotarget; 2015 Dec; 6(41):43779-90. PubMed ID: 26575421
[TBL] [Abstract][Full Text] [Related]
2. Preparation of psoralen polymer-lipid hybrid nanoparticles and their reversal of multidrug resistance in MCF-7/ADR cells.
Huang Q; Cai T; Li Q; Huang Y; Liu Q; Wang B; Xia X; Wang Q; Whitney JCC; Cole SPC; Cai Y
Drug Deliv; 2018 Nov; 25(1):1056-1066. PubMed ID: 29695174
[TBL] [Abstract][Full Text] [Related]
3. GE11 peptide-conjugated nanoliposomes to enhance the combinational therapeutic efficacy of docetaxel and siRNA in laryngeal cancers.
Xu WW; Liu DY; Cao YC; Wang XY
Int J Nanomedicine; 2017; 12():6461-6470. PubMed ID: 28919747
[TBL] [Abstract][Full Text] [Related]
4. Codelivery of BV6 and anti-IL6 siRNA by hyaluronate-conjugated PEG-chitosan-lactate nanoparticles inhibits tumor progression.
Salimifard S; Karoon Kiani F; Sadat Eshaghi F; Izadi S; Shahdadnejad K; Masjedi A; Heydari M; Ahmadi A; Hojjat-Farsangi M; Hassannia H; Mohammadi H; Boroumand-Noughabi S; Keramati MR; Jadidi-Niaragh F
Life Sci; 2020 Nov; 260():118423. PubMed ID: 32941896
[TBL] [Abstract][Full Text] [Related]
5. Phospholipid-modified PEI-based nanocarriers for in vivo siRNA therapeutics against multidrug-resistant tumors.
Essex S; Navarro G; Sabhachandani P; Chordia A; Trivedi M; Movassaghian S; Torchilin VP
Gene Ther; 2015 Mar; 22(3):257-266. PubMed ID: 25354685
[TBL] [Abstract][Full Text] [Related]
6. Biocompatible and colloidally stabilized mPEG-PE/calcium phosphate hybrid nanoparticles loaded with siRNAs targeting tumors.
Gao P; Zhang X; Wang H; Zhang Q; Li H; Li Y; Duan Y
Oncotarget; 2016 Jan; 7(3):2855-66. PubMed ID: 26625203
[TBL] [Abstract][Full Text] [Related]
7. A redox-sensitive micelle-like nanoparticle self-assembled from amphiphilic adriamycin-human serum albumin conjugates for tumor targeted therapy.
Chen L; Chen F; Zhao M; Zhu X; Ke C; Yu J; Yan Z; Zhang F; Sun Y; Chen D; Jiang C; Zhao X; Gao Y; Guo S; Li W
Biomed Res Int; 2015; 2015():987404. PubMed ID: 26075280
[TBL] [Abstract][Full Text] [Related]
8. HER2 siRNA Facilitated Gene Silencing Coupled with Doxorubicin Delivery: A Dual Responsive Nanoplatform Abrogates Breast Cancer.
M G A; K S A; B S U; P L R; H P S; J S; Joseph MM; T T S
ACS Appl Mater Interfaces; 2024 May; 16(20):25710-25726. PubMed ID: 38739808
[TBL] [Abstract][Full Text] [Related]
9. Aerosol delivery of stabilized polyester-siRNA nanoparticles to silence gene expression in orthotopic lung tumors.
Yan Y; Zhou K; Xiong H; Miller JB; Motea EA; Boothman DA; Liu L; Siegwart DJ
Biomaterials; 2017 Feb; 118():84-93. PubMed ID: 27974266
[TBL] [Abstract][Full Text] [Related]
10. SiRNA-Mediated Knockdown of ABCB1 Enhances the Efficacy of Doxorubicin and Vinorelbine in Breast Cancer Cells.
Abbasfard Z; Behzad-Behbahani A; Rastegari B; Naeimi S; Moghanibashi M; Safari F
Curr Pharm Biotechnol; 2024 Apr; ():. PubMed ID: 38616741
[TBL] [Abstract][Full Text] [Related]
11. Titanium dioxide nanostructure-loaded Adriamycin surmounts resistance in breast cancer therapy: ABCA/P53/C-myc crosstalk.
Abdel-Megeed RM; Abdel-Hamid AZ; Kadry MO
Future Sci OA; 2024; 10(1):FSO979. PubMed ID: 38827789
[TBL] [Abstract][Full Text] [Related]
12. Inhibition effects of acridone on the growth of breast cancer cells in vivo.
Xia YF; Chu HJ; Kuang GF; Jiang GJ; Che YC
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2356-2363. PubMed ID: 29762857
[TBL] [Abstract][Full Text] [Related]
13. Liposomal nanocarriers containing siRNA as small molecule-based drugs to overcome cancer drug resistance.
Safaei M; Khalighi F; Behabadi FA; Abpeikar Z; Goodarzi A; Kouhpayeh SA; Najafipour S; Ramezani V
Nanomedicine (Lond); 2023 Oct; 18(24):1745-1768. PubMed ID: 37965906
[TBL] [Abstract][Full Text] [Related]
14. Nanotherapy silencing the interleukin-8 gene produces regression of prostate cancer by inhibition of angiogenesis.
Aalinkeel R; Nair B; Chen CK; Mahajan SD; Reynolds JL; Zhang H; Sun H; Sykes DE; Chadha KC; Turowski SG; Bothwell KD; Seshadri M; Cheng C; Schwartz SA
Immunology; 2016 Aug; 148(4):387-406. PubMed ID: 27159450
[TBL] [Abstract][Full Text] [Related]
15. Optimization of lipid assisted polymeric nanoparticles for siRNA delivery and cancer immunotherapy.
Lin S; Jing H; Du X; Yang X; Wang J
Biomater Sci; 2024 Apr; 12(8):2057-2066. PubMed ID: 38469870
[TBL] [Abstract][Full Text] [Related]
16. siRNA delivery to the glomerular mesangium using polycationic cyclodextrin nanoparticles containing siRNA.
Zuckerman JE; Gale A; Wu P; Ma R; Davis ME
Nucleic Acid Ther; 2015 Apr; 25(2):53-64. PubMed ID: 25734248
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterizations of multidrug-resistant human cancer cells by a biodegradable nano-sensor.
Weng WH; Wang CY; Yan ZY; Lee HT; Kao CY; Chang CW
Biosens Bioelectron; 2024 Apr; 249():115985. PubMed ID: 38219465
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound-targeted microbubble destruction improves the suppression and magnetic resonance imaging of pancreatic cancer with polyethyleneimine nanogels.
Liu Y; Deng Y; Constanthin PE; Li F
J Cancer; 2024; 15(10):2880-2890. PubMed ID: 38706910
[TBL] [Abstract][Full Text] [Related]
19. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J
Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle siRNA against BMI-1 with a Polyethylenimine-Laminarin Conjugate for Gene Therapy in Human Breast Cancer.
Ren X; Liu L; Zhou Y; Zhu Y; Zhang H; Zhang Z; Li H
Bioconjug Chem; 2016 Jan; 27(1):66-73. PubMed ID: 26629893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
